By a combination of chemical and spectroscopic (XH and 13C NMR)studies the structure of a glycopeptide antibiotic eremomycin has been elucidated. It is closely related to vancomycin, but differs in sugar and chlorine content. The eremomycinaglycone contains monodechlorovancomycinic acid; the only chlorine atom is situated in the second amino acid after the TV-terminal amino acid residue of the peptide. The sugar part is composed of glucose and two residues of an amino sugar shown to be 2,3,6-trideoxy-3-amino-C-3-methyl-L-flraZ?z>2o-hexopyranose (4-<?/?/-vancosamine). One of the amino sugar residues is a component of the disaccharide
(Received for publication April 10, 1989) By a combination of chemical and spectroscopic (XH and 13C NMR)studies the structure of a glycopeptide antibiotic eremomycin has been elucidated. It is closely related to vancomycin, but differs in sugar and chlorine content. The eremomycinaglycone contains monodechlorovancomycinic acid; the only chlorine atom is situated in the second amino acid after the TV-terminal amino acid residue of the peptide. The sugar part is composed of glucose and two residues of an amino sugar shown to be 2,3,6-trideoxy-3-amino-C-3-methyl-L-flraZ?z>2o-hexopyranose Eremomycin is identical to the recently obtained antibiotic A82846Aand is very similar to orienticin A but differs from it only in the position of a chlorine. Eremomycinwas isolated from the culture filtrate of actinomycete numbered INA-238 by means of an ion exchange technique1}. Taxonomic studies of the producing culture will be published elsewhere. Eremomycinwas obtained as a homogenouscrystalline sulfate and on the basis of its chemical and biological properties was identified as a new memberof the vancomycin group of antibiotics2). In vivo studies showedthat eremomycinis more active and less toxic then vancomycin and ristomycin3'4). It does not cause local tissues damage and therefore may be used not only for intravenous but also for intramuscular injections. Eremomycinis nowon clinical trial. In this paper evidence for the structure of eremomycin is presented (Fig. 1 ).
Results and Discussion
The molecular formula of eremomycin C73H89N10O26Cl, MW1,556 was determined by elemental analysis and fast atom bombardment (FAB)-MS, ra/z 1,557.6 (M +H)+. The physico-chemical properties of eremomycin sulfate (C73H89N10O26Cl-H2SO4) are as follows: [a]^0 -100°(c 1, H2O); isoionic point 8.3; UV CNHC1nm (E1^) 280 (42), A°a°xlNNaOH 300 (60).
The bathochromic shift of maximumin UVspectrum indicated the presence of the phenolic groups. IR spectrum showed an absorption at 3350cm"1 (NH/OH), intense amide peaks at 1650 and 1500cm"1; absorption at 1200-1000cm"1 (C-O of sugars); a sharp band at 1220cm"1 (C-O) typical of all known antibiotics of this group, apparently reflecting the presence of a triphenyl ether moiety.
Structure of the Aglycone For the determination of amino acid content eremomycinwas exposed to reductive hydrolysis with HI in presence of red phosphorous5). Four ninhydrin positive products were isolated from the hydrolysate and separated by ion-exchange column chromatography on Dowex50X4 (Scheme 1). Twoof them were identified as iV-methyl-D-leucine and L-aspartic acid by paper chromatography, :H NMR spectroscopy and optical rotation. The structure of the biphenyl moiety 1 was confirmed by 1H NMRspectrum of its (9-methyl derivative 3. Tri-amino-tri-carboxylic acid was found to be dideoxymonodechlorovancomycinic acid (2) . 1HNMRspectrum of this compoundcontained signals of nine aromatic protons and indicated the presence of one glycine and two alanine residues linked with benzene nuclei. The substitution patterns were confirmed by the *H NMRanalysis of the oxidative degradation product 4. Both 2 and 4 had only one chlorine atom.
Eremomycincontains the triphenoxy fragment with two residues of serine instead of alanine found in compound 2. As will be shown later one of the alcoholic groups is responsible for the reaction of retroaldol cleavage and another one appeared to be glycosylated with an amino sugar.
To establish the structure of the peptide chain of eremomycin it was sufficient to determine the sequence of three amino acid residues at the JV-terminal part of the molecule. For this purpose the antibiotic was subjected to Edman degradation. The first step resulted in parathyroid hormone(PTH)-JVmethylleucine. On the second step, PTH-glycine was formed as a result of retroaldol destruction of the phenylserine fragment during the reaction with phenylisothiocyanate in alkaline solution. Therefore the serine residue with free hydroxyl is second in the sequence. Onthe third step of degradation with failed to distinguish PTH-aspartic acid. Howeverfree aspartic acid together with PTH-glycine were released on the second step of degradation of the peptide yielding partial hydrolysis of the aglycone but having the same amino acid content. This result demonstrated the cleavage of the peptide bond in the aglycone, involving the carboxyl of aspartic acid, and confirmed that this amino acid residue is the third after the N-terminal.
To clarify the position of chlorophenylserine residue eremomycin was exposed to one step of the Edmanreaction and, after separation of A^-methylleucine, was oxidized first with ninhydrin and then with The other aromatic protons gave signals in the region 6.7~7.24ppm. The splitting patterns of the downfield signals demonstrated that the carboxyl is situated on the chlorine-containing 1,2,4-substituted nucleus. This nucleus is the second after the TV-terminal residue because that was the residue exposed to oxidation. It should be pointed out that all other antibiotics of the vancomycin group with monodechlorovancomycinicacid in their aglycones have a chlorine-containing residue in the region of the C-terminus. The structure of the eremomycin aglycone differs from that of vancomycin in the absence of one chlorine atom in the C-terminal part of molecule6).
Structure and Position of Sugars
The carbohydrate moiety of eremomycin consists of one mol of glucose and two mol of an amino sugar, 4-e>/?/-vancosamine. Mild acid hydrolysis of the antibiotic shows three stages of carbohydrate cleavage (Scheme 2). The identity of amino sugars isolated at the first and third stages was proved by comparing 1H NMRspectra of their methyl A^,O-acetylglycosides. Analysis of the spectral data suggested eremosamine to be 2,3,6-trideoxy-3-amino-C-3-methylhexose with axial protons at C-4 and C-5. It was designated as an L-sugar because the a-anomer of the derivative appeared to be levorotatory but the /?-anomer was dextrorotatory. Equatorial orientation of the amine group at C-3 was established from the negative shift of the optical rotation value of methyl 4-e/?/-vancosaminide copper-ammoniacomplex7).
On the basis of the above data the structure of 2,3,6-trideoxy-3-amino-C-3-methyl-L-^ra/?z>io-hexopyranose (4-e/?z-vancosamine) was proposed for this amino sugar8). In order to determine the position of carbohydrate residues eremomycinand products of mild acid hydrolysis El and E2 were methylated with diazomethane to modify phenolic hydroxyls. Acid hydrolysates (AcOH-HC1, 1 : 1) of all derivatives were found to contain 3. Therefore the phenolic groups of the biphenyl moiety are not substituted with sugars. Monodechlorovancomycinic acid was destroyed under HC1
hydrolysis. To estimate its linkage with sugars the methylated eremomycin, El and E2 were oxidized with potassium permanganate in a weakly alkaline medium. A stable product of oxidation 4 obtained only from O-methyl E2, which had no glucose, demonstrated that the phenolic group of triphenyl ether moiety in eremomycin and El was substituted by this sugar.
Scheme2. Sequence of carbohydrates liberation.
In E2 all phenolic groups are free, hence 4-e/?z-vancosamine can be linked in this compound only through one of the serine hydroxyls. It was already mentioned that the serine residue adjacent to the N-terminus has a free hydroxyl (release of PTH-glycine in process of Edmandegradation). Thus the amino sugar in E2 is evidently located in the C-terminal part of the peptide. The second molecule of 4-e/?/-vancosamine was shown to be attached to the aglycone through glucose. From the methanolysate of permethylated eremomycin (CH3I, DMSO,powdered NaOH)methyl tri-O-methylglucoside was isolated whereas in the case of El under the same conditions methyl tetra-O-methylglucoside was obtained. Acetylation of the partly methylated methylglucoside and separation of the resulting products by silica gel column chromatography yielded a-and /?-anomers of methyl tri-O-methyl-O-acetylglucoside. *HNMRspectra of these compounds revealed the presence of a low field signal at <5 4.7~4.8 near to the 1-H signal. It was assigned to 2-H because one of the coupling constants of this proton in the spectrum of the a-anomer was significantly less (4Hz) than that in the spectrum of the jS-anomer (8 Hz). Thus the disaccharide moiety of eremomycin is 2-O-(4-e/?/-vancosaminyl)-Dglucopyranose. The l ->2 type of glycoside bond is characteristic of the vancomycin group antibiotics. The configuration of the glycosidic links in eremomycin was determined by means of 1 3C/XHcorrelation NMRtechnique. The coupling constant iJCH for the C-l glucose residue was found to be 165 Hz indicating the jS-confmgration. The constants 172.5 and 170.5 Hz for the C-l amino sugar residues in the disaccharide moiety and attached through the serine hydroxyl (respectively) were in accordance with the a-conflguration of their glycosidic bonds.
The Primary Amide Group and Related Reaction of Eremomycin
Eremomycin is an amphoteric substance. Potentiometric titration revealed three amino, one carboxyl and three phenolic groups in the molecule (Fig. 2) . Isoionic point 8.3 was measured as a pH value of the solution deionized with suitable ion-exchangers. Eremomycinhas no ester bonds (IR spectrum) but carries one primary amide that causes liberation of one mol ammonia at mild acid hydrolysis (1 n HC1, 105°, 1 hour). Its location on the asparagine residue follows from the ability of eremomycinto undergo a-»/J transpeptidation as described for vacomycin9) and some peptides10). The rearrangement does not occur in the case ofpeptides containing aspartic acid residues with a free /2-COOH.
Under conditions reported for vancomycin transformation (H2O, pH4.0, 70°C, 40 hours) eremomycin gave an inactive product (E-oc-COOH) with a net charge of +1 (three amino and two carboxyl groups) which was separated by CMcellulose column chromatography in a gradient of ammonium acetate (Fig. 3 ). Another compound with the same charge but possessing significant activity was isolated from the solution of antibiotic in saturated Ba(OH)2 after 3~5 hours incubation at 37°C. It differed from E-a-COOH in chromatographic behavior (CM-cellulose column, TLC, PC) and was assumed to be deamidoeremomycin (E-/?-COOH). Deglycosylation of eremomycin during mild acid hydrolysis was also followed by the reactions of transpeptidation and deamidation. After all carbohydrates had been released (1 n HC1, 100°C, 1 hour) three aglycones were found in the hydrolysate; a neutral (trace amounts) and two acidic aglycones with an overall charge of -1 (one amino and two carboxyl groups). They were identified as Agl-CONH2, Agl-jS-COOHand Agl-a -COOHon the basis of their relation oferemomycin, E-^-COOHand E-a-COOH (respectively) established by the method of specific deglycosylation with anhydrous TFA -HCl11*. Only a neutral aglycone was obtained from eremomycin indicating that deamidation and transpeptidation do not take place under these conditions. In contrast to the other aglycones, Agl-a-COOH was composed of two closely related components (TLC, EtOAc-BuOH-AcOH-H2O, 7 :2:4:2), supposed to be geometric isomers, differing in the orientation of chlorine atom. Whenthis manuscript was in preparation, the structures of the glycopeptide antibiotics orienticins12) and A8284613) were reported. Amongthem the antibiotic A82846Awas found to be identical to eremomycin and orienticin A differs from it only in containing a chlorine in the phenylserine residue, the second after the C-terminus instead of in the second after the N-terminus. DEC. 1989 Experimental General UVspectra were determined on a Beckman UV5260 spectrometer, IR spectra were determined on a Beckman 620 MXinstrument in KBr, NMRspectra were recorded on a Varian XL-100 and Bruker WP-200 SY spectrometers. Chemical shifts (S) were expressed in ppm down field from an internal TMS reference. A molecular weight was obtained by FAB-MSon a Kratos MS-50 instrument. Optical rotations were measured with a Perkin-Elmer polarimeter. Potentiometric titration was performed on a titrator TTT-1 supplied with titrigraph SBR-2 and microburette SBU-1 (Radiometer, Denmark), with glass and calomel electrodes in solution H2O-EtOH, 4: 1. The data below pH 3 and above pH 10 were corrected by means of blank titration. CM-cellulose column chromatography was performed on a LKBUltrograd gradient mixer 11300 with Uvicord 2138 and Recorder 2065. Precoated Merck Silica gel 60 F254 plates were used for TLC in systems PrOH-EtOAc-coned NH4OH,1.5: 1.5:2.0 (E, El, E2, Agl et aL); CHC13 (PTH amino acids); CHCl3-MeOH,9 : 1 and C6H6-Me2CO,7 : 3 (sugar derivatives).
Whatman N2 was used for paper chromatography in systems BuOH-AcOH-H2O, 2: 1 : 1 (amino acids); BuOH-C5H5N- 5: 3 : 32, upper phase (E, El, E2, Agl, E-£-COOH, E-a-COOH, Agl-^-COOH, Agl-a-COOH). Paper electrophoresis was carried out in 2n AcOHat 700V for 3 hours and in 0.5m C5H5N-AcOHbuffer pH 5.6 at 900V for 3 hours.
Acid Hydrolysis of Eremomycin
A solution of eremomycin (lOOmg/ml) was heated in 57% HI with red phosphorus (20mg/ml) for 6 hours or in 2N HC1for 12 hours under reflux. Aminoacids were separated by column chromatography on Dowex 50X4 using 0.1 n pyridine-AcOH buffer pH 3.65 for aliphatic and pH4.7 for aromatic amino 7V-Acetylation and Methylation N-Acetylation and methylation of eremomycin, El and E2 were carried out by the method described previously1 4).
Tri-0-methylactmoidinic
Acid (3) A solution of N-acetyl-O-methyleremomycin in AcOH-10n HC1, 1 : 1 (lOOmg/ml) was refluxed for 6 hours. After filtration and evaporation of the hydrolysate the residue was dissolved in water and the solution adjusted to pH 7.0 was applied to a column (H=50cm) of Sephadex G-25 developed with 0.1 n AcOHin H2O-EtOH, 9 : 1. The fractions were analyzed by paper chromatography. Compound 3 was isolated as a white foam: *H NMR(100MHz, CD3OD) S 3.62 (3H, s, OCH3), 3.68 (3H, s, OCH3), 3.82 (3H, s, OCH3), 4.54 (1H, s, a-CH), 4.97 (1H, s, a-CH 
Compound5
Compound5 was obtained from eremomycin by the method previously described for the preparation of "amino acid Z" from actinoidin16). The purification of 5 was carried out on Sephadex G-25 column (H=80cm) with eluent 0.1 n AcOHin H2O-EtOH, 9: 1. The aqueous solution after extraction was adjusted to pH 3.0 with Dowex 2X4 (OH)~and evaporated, the residue was exposed to the second step of degradation. PTH-glycine was identified by direct comparison with an authentic sample.
4-e/H-Vanco samine
A solution oferemomycin sulfate (7 g) in 1 n HC1 (70ml) was refluxed for 1 hour, then cooled, filtered, diluted with H2O (1 :4) A solution of4-e7?/-vancosamine (0.38 g) in 1 n HC1 methanolic solution (38 ml) was heated for 1 hour under reflux. The methanolysate after cooling was diluted with ice-water, neutralized with anion exchanger (pH 6.0) and evaporated. The resulting residue was crystallized from MeOH-Et2O, 1 : 5 to yield 50mg of a-methyl-4-^/-vancosaminide:
[a]£°-116°(c 1. Methyl 7V, O-Acetyl-4-ei/?/-vancosaminide The solution resulted after separation of a-methyl-4-e/?/-vancosaminide (see above) was evaporated the residue dissolved in C5H5N(2ml), acetic anhydride (1.2ml) was added and mixture was left overnight at room temperature, then poured into H2O(20ml) and extracted with CHC13 (20ml x 3). The combined extract was washed with 0.5n H2SO4and H2O. After removal of CHC13the residue was purified by Kieselgel 40 Merck column chromatography developed with C6H6 -(CH3)2CO, 9 : 1. Two main products were afforded as white crystals:
Methyl A^0-Acetyl-a-L- Methyl 4-e/7/-Vancosaminide CuprammoniumComplex The solution (3 ml) of methyl eremosaminide in water was evaporated, the residue was dissolved in 3ml 4% tetrammincopper (ll) sulfate ( A mixture oferemomycin (1.5 g), DMSO(24ml), powdered NaOH (3 g) and CH3I (3.7ml) was stirred at room temperature for 2 hours. Then NaOHwas filtered off and the solution extracted with CHC13.After washing with water the extract was evaporated and the residue reprecipitated with ether from EtOH. The resulting product was dissolved in 1 n HC1 -MeOHand the solution (40mg/ml) was heated under reflux for 2 hours then cooled and diluted with H2O(1 : 1). The precipitate was filtered off and the solution was adjusted to pH 6.5 with anion-exchanger and evaporated. The residue was treated with ethanol -ether, 1 : 10. The soluble fraction was purified by column chromatography (Kieselgel 40 Merck, 1 x27cm, C6H6-Me2CO, 9: 1) and acetylated with acetic anhydride in pyridine (1 : 1.5) at 20°C for 18 hours. 
